Data on sensitivity and specificity of the CellSearch platform based on immunofluorescence detection of HMW-MAA, CD45 and CD34 for patients with melanoma were reported in two patients only [72] due to the decision of the company to not pursue further development of the technique. The gene discussed is PTPRC; the disease is melanoma.